baCta
Using microorganisms as programmable molecular factories for industrial ingredients.
About
baCta is an AI-powered bioproduction company focused on industrial ingredients, starting with b-Astaxanthin. They utilize a platform combining AI models, precision biofoundry automation, and standardized bioprocesses to achieve predictive throughput and efficient scaling for high-quality product output. Their mission is to produce valuable molecules with microorganisms, paving the way for sustainable abundance of industrial ingredients.
Key facts
- Website
- bacta.bio
- Headquarters
- Paris, France
- Founded
- 2021
- Total funding
- $7M (Seed)
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechnologySynthetic BiologyIndustrial BiotechnologyChemicals
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Mar 2026 | Seed | $7M | - |
Tech stack
Detected on bacta.bio, last scanned 4 Sept 2026. Run your own scan
- Email provider
- Google Workspace
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Frequently asked
How much funding has baCta raised?
baCta has raised a total of $7M in funding. The most recent round on record is Seed.